Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-11-30 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion +666 $5.17 $3K 666
2021-11-30 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion +2,936 $0.77 $2K 3,602
2021-11-30 Echerd Margaret SVP, Principal Accntng Officer Sale −3,602 $8.00 $29K 0
2021-11-30 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion · Stock Option (right to buy) −666 1,667
2021-11-30 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion · Stock Option (right to buy) −2,936 26,416
2021-10-12 Yedid Robert A. Director Gift −1,500 6,740
2021-10-12 Yedid Robert A. Director Gift −1,500 5,240
2021-10-12 Yedid Robert A. Director Gift −1,500 3,740
2021-10-12 Yedid Robert A. Director Gift +1,500 1,500
2021-09-10 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion +334 $5.17 $2K 334
2021-09-10 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion +1,467 $0.77 $1K 1,801
2021-09-10 Echerd Margaret SVP, Principal Accntng Officer Sale −1,801 $9.10 $16K 0
2021-09-10 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion · Stock Option (Right to Buy) −334 2,333
2021-09-10 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion · Stock Option (Right to Buy) −1,467 29,352
2021-08-20 Cherrington Julie M Director Grant or award · Stock Option (right to buy) +65,700 65,700
2021-08-10 Tucker Sean SVP, Chief Scientific Officer Sale −4,172 $10.20 $43K 43,881
2021-08-10 Tucker Sean SVP, Chief Scientific Officer Sale −5,828 $10.20 $59K 51,465
2021-08-10 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion +333 $5.17 $2K 333
2021-08-10 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion +1,468 $0.77 $1K 1,801
2021-08-10 Echerd Margaret SVP, Principal Accntng Officer Sale −1,801 $10.00 $18K 0

Page 11 of 23 · 442 trades